Literature DB >> 12169267

Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1)H magnetic resonance spectroscopy.

Guillem Massana1, Cristóbal Gastó, Carme Junqué, José-María Mercader, Beatriz Gómez, Joan Massana, Xavier Torres, Manel Salamero.   

Abstract

In vivo proton magnetic resonance spectroscopy ((1)H MRS) was used to study possible neurochemical abnormalities in drug-free, symptomatic panic disorder patients at rest. (1)H MRS was performed in 11 panic disorder patients and 11 healthy age- and sex-matched comparison subjects. Levels of brain metabolites were determined in the right medial temporal lobe region (encompassing the whole amygdala and part of the hippocampus) and in the medial prefrontal cortex on the basis of previous work with both structural and functional neuroimaging techniques. The concentration of creatine and phosphocreatine, metabolites involved in energy-dependent systems in brain, was significantly lower in the right medial temporal lobe region of panic disorder patients compared to healthy subjects. No significant differences between the two groups were observed in the medial prefrontal cortex. These results provide neurochemical evidence suggesting the involvement of the amygdalohippocampal region in the pathogenesis of panic disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169267     DOI: 10.1006/nimg.2002.1083

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  12 in total

Review 1.  Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder.

Authors:  Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

Review 2.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

3.  Early-life stress and neurometabolites of the hippocampus.

Authors:  Jeremy D Coplan; Sanjay J Mathew; Chadi G Abdallah; Xiangling Mao; John G Kral; Eric L P Smith; Leonard A Rosenblum; Tarique D Perera; Andrew J Dwork; Patrick R Hof; Jack M Gorman; Dikoma C Shungu
Journal:  Brain Res       Date:  2010-08-14       Impact factor: 3.252

4.  Panic-focused psychodynamic psychotherapy in a woman with panic disorder and generalized anxiety disorder.

Authors:  Larry Sandberg; Fredric Busch; Franklin Schneier; Andrew Gerber; Eve Caligor; Barbara Milrod
Journal:  Harv Rev Psychiatry       Date:  2012 Sep-Oct       Impact factor: 3.732

Review 5.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

6.  Prefrontal cortical gamma-aminobutyric Acid levels in panic disorder determined by proton magnetic resonance spectroscopy.

Authors:  Gregor Hasler; Jan Willem van der Veen; Marilla Geraci; Jun Shen; Daniel Pine; Wayne C Drevets
Journal:  Biol Psychiatry       Date:  2008-08-09       Impact factor: 13.382

7.  Decreased GABA levels in anterior cingulate cortex/medial prefrontal cortex in panic disorder.

Authors:  Zaiyang Long; Carla Medlock; Mario Dzemidzic; Yong-Wook Shin; Andrew W Goddard; Ulrike Dydak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-02-04       Impact factor: 5.067

8.  Hippocampal neurochemical pathology in patients with panic disorder.

Authors:  Murad Atmaca; Hanefi Yildirim; M Gurkan Gurok; Muammer Akyol; Filiz Koseoglu
Journal:  Psychiatry Investig       Date:  2012-04-30       Impact factor: 2.505

9.  The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies.

Authors:  Jieun E Kim; Stephen R Dager; In Kyoon Lyoo
Journal:  Biol Mood Anxiety Disord       Date:  2012-11-20

Review 10.  Neuroimaging in anxiety disorders.

Authors:  Kirsten Engel; Borwin Bandelow; Oliver Gruber; Dirk Wedekind
Journal:  J Neural Transm (Vienna)       Date:  2008-06-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.